Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1994-5-27
|
pubmed:abstractText |
The effect of central administration of the endogenous peptide Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) on the gastrointestinal myoelectric activity and its mechanism of action were studied in rats. Tyr-MIF-1 (40 & 80 micrograms/kg i.c.v.) stimulated antral and duodenal myoelectric activity in a multiphasic manner. On the antrum it induced a primary increase of the frequency of antral spike bursts followed by a consecutive return to control value and a second rise of the frequency. Likewise duodenal migrating myoelectric complexes (MMCs) were initially disrupted and replaced by an irregular spiking activity followed by a reaparition of the phase III of the MMCs with increased amplitude and frequency. Haloperidol (1 mg/kg i.p.) blocked all the effects of Tyr-MIF-1 whereas sulpiride (5 mg/kg s.c.) blocked only the duodenal stimulation without affecting that on the antrum. Similarly BMY-14802 (0.5 mg/kg s.c.) antagonized selectively the primary antral stimulation and the initial disruption of duodenal MMC induced by Tyr-MIF-1. L365 260 (10 micrograms/kg i.c.v.) has also antagonized only the initial disruption of duodenal MMCs. DTG and JO 1784 (100 micrograms/kg i.c.v. each) reproduced fully the effect of Tyr-MIF-1 on the duodenum but not that on the antrum. Domperidone, (+)SCH 23390, devazepide, PK 11-195 and flumazenil did not have effect on the action of Tyr-MIF-1. It is concluded that Tyr-MIF-1 stimulates the antrum involving haloperidol sensitive but nondopamine, dopamine, probably sigma receptors, and the duodenum via a pathway where central D2 dopamine, sigma and CCKB receptors are implied.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Dopamine Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/GABA-A Receptor Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/MSH Release-Inhibiting Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cholecystokinin,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Dopamine,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, GABA-A,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, sigma,
http://linkedlifedata.com/resource/pubmed/chemical/tyrosyl-prolyl-leucyl-glycinamide
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0143-4179
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
77-85
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:7909585-Action Potentials,
pubmed-meshheading:7909585-Amino Acid Sequence,
pubmed-meshheading:7909585-Animals,
pubmed-meshheading:7909585-Dopamine Antagonists,
pubmed-meshheading:7909585-Duodenum,
pubmed-meshheading:7909585-Electromyography,
pubmed-meshheading:7909585-GABA-A Receptor Antagonists,
pubmed-meshheading:7909585-Gastrointestinal Motility,
pubmed-meshheading:7909585-MSH Release-Inhibiting Hormone,
pubmed-meshheading:7909585-Male,
pubmed-meshheading:7909585-Molecular Sequence Data,
pubmed-meshheading:7909585-Rats,
pubmed-meshheading:7909585-Rats, Wistar,
pubmed-meshheading:7909585-Receptors, Cholecystokinin,
pubmed-meshheading:7909585-Receptors, Dopamine,
pubmed-meshheading:7909585-Receptors, GABA-A,
pubmed-meshheading:7909585-Receptors, sigma
|
pubmed:year |
1994
|
pubmed:articleTitle |
Central administration of Tyr-MIF-1 stimulates gastrointestinal motility in rats: evidence for the involvement of dopamine, sigma and CCK receptors.
|
pubmed:affiliation |
Department of Pharmacology, INRA BP3, Toulouse.
|
pubmed:publicationType |
Journal Article
|